Newsfeeds - Spark Newswire

1 minute read

General

Amyris Announces Launch Of Rose Inc.

Today, 5:41 AM

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients,

AMRS

5 minute read

58 Biggest Movers From Friday

By Lisa Levin

Today, 5:41 AM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

AMRS

2 minute read

FDA
News

Amyris Highlights In-Vivo Results In Study Of Its Licensed RNA Vaccine Through Intranasal Delivery

By Benzinga Newsdesk

Today, 5:41 AM

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced

AMRS

1 minute read

General

Amyris Launches Terasana Clinical Clean Skincare Brand

By Bill Haddad

Today, 5:41 AM

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch

AMRS

2 minute read

Movers

Understanding Amyris’s Unusual Options Activity

By Benzinga Insights

Today, 5:41 AM

Shares of Amyris (NASDAQ:AMRS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $14.85.

AMRS

1 minute read

Roth Capital Maintains Buy on Amyris, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 5:41 AM

Roth Capital analyst Craig Irwin maintains Amyris (NASDAQ:AMRS) with a Buy and lowers the price target from $25 to $22.

AMRS

1 minute read

Oppenheimer Maintains Outperform on Amyris, Raises Price Target to $26

By Benzinga Newsdesk

Today, 5:41 AM

Oppenheimer analyst Colin Rusch maintains Amyris (NASDAQ:AMRS) with a Outperform and raises the price target from $25 to $26.

AMRS

1 minute read

HC Wainwright & Co. Maintains Buy on Amyris, Lowers Price Target to $30

By Benzinga Newsdesk

Today, 5:41 AM

HC Wainwright & Co. analyst Amit Dayal maintains Amyris (NASDAQ:AMRS) with a Buy and lowers the price target from $35 to $30.

AMRS

1 minute read

Amyris Q2 EPS $(0.15) Misses $(0.13) Estimate, Sales $52.32M Miss $53.73M Estimate

By Benzinga Newsdesk

Today, 5:41 AM

Amyris (NASDAQ:AMRS) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 53.13 percent increase over losses of $(0.32) per share from the same

AMRS

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 5:41 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI